Document is current
Any future updates will be listed below
-
Authors
Bohrer, Laura R.
Stone, Nicholas E.
Mullin, Nathaniel K.
Voigt, Andrew P.
Anfinson, Kristin R.
Fick, Jessica L.
Luangphakdy, Viviane
Hittle, Bradley
Powell, Kimerly
Muschler, George F.
Mullins, Robert F.
Stone, Edwin M.
Tucker, Budd A. http://orcid.org/0000-0003-2178-1742
-
Funding
Funding for this research was provided by:
National Institutes of Health (RO1 EY033331)
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 3 February 2023
First Online: 28 February 2023
Declarations
:
: This study was approved by the Institutional Review Board of the University of Iowa (project approval #200202022) and adhered to the tenets set forth in the Declaration of Helsinki.
: Not Applicable.
: KP is a paid consultant and shareholder in Cell X Technologies Inc. GM is the Chief Technology Officer and shareholder in Cell X Technologies Inc. VL is an employee and shareholder in Cell X Technologies Inc.
